NTRP:OTCQB-Neurotrope Inc (USD)

COMMON STOCK | Travel Services | OTCQB - U.S. Registered

Last Closing

USD 2.3

Change

0.00 (0.00)%

Market Cap

USD 0.14B

Volume

5.95K

Analyst Target

USD 1.00
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Neurotrope Inc is a development stage company. The Company is a clinical stage biopharmaceutical and diagnostics company, engaged in developing drug candidate called bryostatin and a diagnostic test for Alzheimer's Disease.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-26 )

Largest Industry Peers for Travel Services

Symbol Name Price(Change) Market Cap
BKNG Booking Holdings Inc

N/A

USD 129.37B
ABNB Airbnb Inc

N/A

USD 92.67B
TCOM Trip.com Group Ltd ADR

N/A

USD 33.47B
EXPE Expedia Group Inc.

N/A

USD 16.30B
MMYT MakeMyTrip Limited

N/A

USD 8.77B
TRIP TripAdvisor Inc

N/A

USD 2.48B
LIND Lindblad Expeditions Holdings ..

N/A

USD 0.40B
TOUR Tuniu Corp

N/A

USD 0.13B
YTRA Yatra Online Inc

N/A

USD 0.08B
ISPO Inspirato Inc

N/A

USD 0.01B

ETFs Containing NTRP

N/A

Market Performance

  Market Performance vs. Industry/Classification (Travel Services) Market Performance vs. Exchange (OTCQB - U.S. Registered)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain -66.91% 25% F 20% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -66.91% 25% F 20% F
Average Annual (5 Year Horizon)  
Capital Gain -4.28% 25% F 35% F
Dividend Return -4.28% 25% F 32% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 25.97% 92% A 68% D+
Risk Adjusted Return -16.50% 25% F 32% F
Market Capitalization 0.14B N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Negative earnings

The company had negative total earnings in the most recent four quarters.